We are live on ! Find out more
ANIK icon

Anika Therapeutics

146 hedge funds and large institutions have $542M invested in Anika Therapeutics in 2021 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 53 increasing their positions, 48 reducing their positions, and 33 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,634% more call options, than puts

Call options by funds: $20.8M | Put options by funds: $762K

10% more repeat investments, than reductions

Existing positions increased: 53 | Existing positions reduced: 48

2.33% less ownership

Funds ownership: 95.22%92.89% (-2.3%)

11% less funds holding

Funds holding: 164146 (-18)

12% less capital invested

Capital invested by funds: $613M → $542M (-$70.7M)

52% less first-time investments, than exits

New positions opened: 16 | Existing positions closed: 33

Holders
146
Holders Change
-18
Holders Change %
-10.98%
% of All Funds
2.56%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
16
Increased
53
Reduced
48
Closed
33
Calls
$20.8M
Puts
$762K
Net Calls
+$20.1M
Net Calls Change
-$2.13M
Name Holding Trade Value Shares
Change
Change in
Stake
CIS
101
Connors Investor Services
Pennsylvania
$232K +$37.9K +1,000 +21%
Walleye Trading
102
Walleye Trading
New York
$201K +$155K +4,097 +497%
MLICM
103
Metropolitan Life Insurance Company (MetLife)
New York
$190K
Bank of Montreal
104
Bank of Montreal
Ontario, Canada
$165K -$569 -15 -0.4%
MPWT
105
MassMutual Private Wealth & Trust
Connecticut
$157K
TRSOTSOK
106
Teachers Retirement System of the State of Kentucky
Kentucky
$134K
FQ
107
First Quadrant
California
$124K -$39.7K -1,046 -26%
Acadian Asset Management
108
Acadian Asset Management
Massachusetts
$90K -$212K -5,598 -72%
MOACM
109
Mutual of America Capital Management
New York
$78K +$4.51K +119 +7%
Lazard Asset Management
110
Lazard Asset Management
New York
$73K -$12.6K -331 -16%
EARNEST Partners
111
EARNEST Partners
Georgia
$61K
US Bancorp
112
US Bancorp
Minnesota
$54K +$43.1K +1,135 +568%
AIP
113
Ameritas Investment Partners
Nebraska
$49K
Zurich Cantonal Bank
114
Zurich Cantonal Bank
Switzerland
$44K
SFS
115
Sowell Financial Services
Arkansas
$41K +$24K +633 +165%
PNC Financial Services Group
116
PNC Financial Services Group
Pennsylvania
$33K -$4.21K -111 -12%
Macquarie Group
117
Macquarie Group
Australia
$28K -$12.2K -322 -32%
Pacer Advisors
118
Pacer Advisors
Pennsylvania
$26K +$1.52K +40 +7%
SWA
119
Sutton Wealth Advisors
Florida
$22.2K
TRCT
120
Tower Research Capital (TRC)
New York
$21K +$4.7K +124 +31%
SWM
121
Spire Wealth Management
Virginia
$16K +$17K +447 New
SPIA
122
Steward Partners Investment Advisory
New York
$12.2K
MSFP
123
Mark Sheptoff Financial Planning
Connecticut
$12K
CAPTRUST Financial Advisors
124
CAPTRUST Financial Advisors
North Carolina
$9K +$7.51K +198 +660%
Fifth Third Bancorp
125
Fifth Third Bancorp
Ohio
$8K +$7.17K +189 New

ANIK Hedge Fund Activity: Q1 2021 in Review

146 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Anika Therapeutics (ANIK) for Q1 2021, worth a combined $542M — down 12% from $613M a quarter earlier.

Sellers outnumbered buyers: 33 funds closed out of ANIK and 16 opened new positions — a net loss of 17 holders — while 48 trimmed existing stakes and 53 added.

The largest buyer was Morgan Stanley, adding an estimated $21.1M. The largest seller was Avidity Partners Management, exiting entirely with an estimated $33.1M sold.

  • 146 institutional investors held Anika Therapeutics (ANIK) as of Q1 2021, down from 164 in Q4 2020.
  • Funds reported $542M of Anika Therapeutics stock for Q1 2021, down 12% quarter-over-quarter.
  • 16 funds opened new Anika Therapeutics positions in Q1 2021 and 33 closed out, a net change of -17 holders.
  • The largest Anika Therapeutics buyer in Q1 2021 was Morgan Stanley, an estimated $21.1M added.
  • The largest Anika Therapeutics seller in Q1 2021 was Avidity Partners Management, an estimated $33.1M sold.

Based on aggregated 13F filings for Q1 2021.